Spedaliere
Christopher Spedaliere, Allentown, PA US
Patent application number | Description | Published |
---|---|---|
20120301901 | GEMCITABINE IMMUNOASSAY - The present invention comprises novel analogs of gemcitabine and novel gemcitabine immunogens leased out of, i.e., derived from, the 5′-hydroxy position of gemcitabine. The invention also comprises unique monoclonal antibodies generated using gemcitabine linked immunogens as well as unique conjugates and tracers which antibodies, conjugates, and tracers are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids. | 11-29-2012 |
20120301902 | Gemcitabine Immunoassay - The present invention comprises novel conjugates and immunogens derived from gemcitabine and unique antibodies generated by using gemcitabine linked immunogens, which conjugates immunogens and antibodies, are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids. | 11-29-2012 |
20120301973 | CLOZAPINE IMMUNOASSAY - Novel conjugates and immunogens derived from clozapine and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of clozapine and N-desmethylclozapine in biological fluids. | 11-29-2012 |
20120301974 | Clozapine Immunoassay - Novel conjugates and immunogens derived from clozapine and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of clozapine in biological fluids. | 11-29-2012 |
20140273023 | GEMCITABINE IMMUNOASSAY - The present invention comprises novel analogs of gemcitabine and novel gemcitabine immunogens teased out of, i.e., derived from, the 5′-hydroxy position of gemcitabine. The invention also comprises unique monoclonal antibodies generated using gemcitabine linked immunogens as well as unique conjugates and tracers which antibodies, conjugates, and tracers are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids. | 09-18-2014 |
20140302618 | Clozapine Immunoassay - Novel conjugates and immunogens derived from clozapine and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of clozapine in biological fluids. | 10-09-2014 |
20150104818 | GEMCITABINE IMMUNOASSAY - The present invention comprises novel conjugates and immunogens derived from gemcitabine and unique antibodies generated by using gemcitabine linked immunogens, which conjugates immunogens and antibodies, are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids. | 04-16-2015 |
Christopher J. Spedaliere, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20160033525 | IMMUNOASSAY STANDARDS AND MEASUREMENT OF TAU USING INTRA-ASSAY CALIBRATION STANDARDS - The present invention provides novel peptides, compositions, and methods for creating quantitative novel compositions, as well as methods for creating quantitative standards to calibrate analytes. These peptides, compositions, and methods enable the creation of standards and calibrators for analyzing analytes and measuring clinical biomarkers (e.g., Tau). Also provided are kits comprising the peptides or compositions described herein, for use in assays (e.g., sandwich immunoassays). | 02-04-2016 |
Davide Spedaliere, Ghiffa IT
Patent application number | Description | Published |
---|---|---|
20140240090 | Solutions for Relay Attacks on Passive Keyless ENTRY and GO - A passive entry system, in particular for a motor vehicle, comprising: a mobile device to be carried by a user, said mobile device comprising a low-frequency transceiver for short range communication, an ultra-high-frequency transceiver for long range communication and information concerning access, such as an access code, which is transmittable by said transceivers; and a locking device which is to be unlocked by the mobile device, said locking device comprising a low-frequency transceiver for short-range communication and an ultra-high frequency transceiver for long range communication to receive said information concerning access, such the access code. The transceivers of the mobile device communicates with the transceiver of the locking device and exchange information concerning access, such as said access code, to the locking system via the respective transceivers, wherein the communication range of the ultra-high-frequency transceiver of the mobile device is limited to a short range in a normal operating mode of the mobile device. | 08-28-2014 |
Gary Spedaliere, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20130114486 | VIRTUALIZED WIRELESS NETWORK WITH PILOT BEACONS - A virtualized DAS network includes one or more digital access units (DAUs) and one or more digital remote units (DRUs) coupled to the one or more DAUs. The virtualized DS network also includes a routing table associated with the one or more DAUs. A signal provided by the one or more DRUs includes one or more carriers and one or more pilot beacons. | 05-09-2013 |
20130128810 | VIRTUALIZED WIRELESS NETWORK - According to an embodiment of the present invention, a network is provided. The network may include a first base transceiver station (BTS). The first BTS may be operable to provide a first signal including a plurality of first carriers. The network may also include a second BTS operable to provide a second signal including a plurality of second carriers. The network may also include a set of one or more digital access units (DAUs), each of the one or more DAUs being coupled to at least one of the first BTS or the second BTS. A set of one or more digital remote units (DRUs) may be included in the network, each of the DRUs being coupled to one of the one or more DAUs and operable to broadcast the first signal or the second signal. | 05-23-2013 |